Cargando…

CEACAM1-4L Promotes Anchorage-Independent Growth in Melanoma

Widespread metastasis is the leading course of death in many types of cancer, including malignant melanoma. The process of metastasis can be divided into a number of complex cell biological events, collectively termed the “invasion-metastasis cascade.” Previous reports have characterized the capabil...

Descripción completa

Detalles Bibliográficos
Autores principales: Löffek, Stefanie, Ullrich, Nico, Görgens, André, Murke, Florian, Eilebrecht, Mara, Menne, Christopher, Giebel, Bernd, Schadendorf, Dirk, Singer, Bernhard B., Helfrich, Iris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609850/
https://www.ncbi.nlm.nih.gov/pubmed/26539411
http://dx.doi.org/10.3389/fonc.2015.00234
_version_ 1782395860770881536
author Löffek, Stefanie
Ullrich, Nico
Görgens, André
Murke, Florian
Eilebrecht, Mara
Menne, Christopher
Giebel, Bernd
Schadendorf, Dirk
Singer, Bernhard B.
Helfrich, Iris
author_facet Löffek, Stefanie
Ullrich, Nico
Görgens, André
Murke, Florian
Eilebrecht, Mara
Menne, Christopher
Giebel, Bernd
Schadendorf, Dirk
Singer, Bernhard B.
Helfrich, Iris
author_sort Löffek, Stefanie
collection PubMed
description Widespread metastasis is the leading course of death in many types of cancer, including malignant melanoma. The process of metastasis can be divided into a number of complex cell biological events, collectively termed the “invasion-metastasis cascade.” Previous reports have characterized the capability of anchorage-independent growth of cancer cells in vitro as a key characteristic of highly aggressive tumor cells, particularly with respect to metastatic potential. Biological heterogeneity as well as drastic alterations in cell adhesion of disseminated cancer cells support escape mechanisms for metastases to overcome conventional therapies. Here, we show that exclusively the carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) splice variant CEACAM1-4L supports an anchorage-independent signature in malignant melanoma. These results highlight important variant-specific modulatory functions of CEACAM1 for metastatic spread in patients suffering malignant melanoma.
format Online
Article
Text
id pubmed-4609850
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-46098502015-11-04 CEACAM1-4L Promotes Anchorage-Independent Growth in Melanoma Löffek, Stefanie Ullrich, Nico Görgens, André Murke, Florian Eilebrecht, Mara Menne, Christopher Giebel, Bernd Schadendorf, Dirk Singer, Bernhard B. Helfrich, Iris Front Oncol Oncology Widespread metastasis is the leading course of death in many types of cancer, including malignant melanoma. The process of metastasis can be divided into a number of complex cell biological events, collectively termed the “invasion-metastasis cascade.” Previous reports have characterized the capability of anchorage-independent growth of cancer cells in vitro as a key characteristic of highly aggressive tumor cells, particularly with respect to metastatic potential. Biological heterogeneity as well as drastic alterations in cell adhesion of disseminated cancer cells support escape mechanisms for metastases to overcome conventional therapies. Here, we show that exclusively the carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) splice variant CEACAM1-4L supports an anchorage-independent signature in malignant melanoma. These results highlight important variant-specific modulatory functions of CEACAM1 for metastatic spread in patients suffering malignant melanoma. Frontiers Media S.A. 2015-10-19 /pmc/articles/PMC4609850/ /pubmed/26539411 http://dx.doi.org/10.3389/fonc.2015.00234 Text en Copyright © 2015 Löffek, Ullrich, Görgens, Murke, Eilebrecht, Menne, Giebel, Schadendorf, Singer and Helfrich. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Löffek, Stefanie
Ullrich, Nico
Görgens, André
Murke, Florian
Eilebrecht, Mara
Menne, Christopher
Giebel, Bernd
Schadendorf, Dirk
Singer, Bernhard B.
Helfrich, Iris
CEACAM1-4L Promotes Anchorage-Independent Growth in Melanoma
title CEACAM1-4L Promotes Anchorage-Independent Growth in Melanoma
title_full CEACAM1-4L Promotes Anchorage-Independent Growth in Melanoma
title_fullStr CEACAM1-4L Promotes Anchorage-Independent Growth in Melanoma
title_full_unstemmed CEACAM1-4L Promotes Anchorage-Independent Growth in Melanoma
title_short CEACAM1-4L Promotes Anchorage-Independent Growth in Melanoma
title_sort ceacam1-4l promotes anchorage-independent growth in melanoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609850/
https://www.ncbi.nlm.nih.gov/pubmed/26539411
http://dx.doi.org/10.3389/fonc.2015.00234
work_keys_str_mv AT loffekstefanie ceacam14lpromotesanchorageindependentgrowthinmelanoma
AT ullrichnico ceacam14lpromotesanchorageindependentgrowthinmelanoma
AT gorgensandre ceacam14lpromotesanchorageindependentgrowthinmelanoma
AT murkeflorian ceacam14lpromotesanchorageindependentgrowthinmelanoma
AT eilebrechtmara ceacam14lpromotesanchorageindependentgrowthinmelanoma
AT mennechristopher ceacam14lpromotesanchorageindependentgrowthinmelanoma
AT giebelbernd ceacam14lpromotesanchorageindependentgrowthinmelanoma
AT schadendorfdirk ceacam14lpromotesanchorageindependentgrowthinmelanoma
AT singerbernhardb ceacam14lpromotesanchorageindependentgrowthinmelanoma
AT helfrichiris ceacam14lpromotesanchorageindependentgrowthinmelanoma